LXRX - Lexicon Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5566
Avg. Estimate0.73-0.42-0.28-1.27
Low Estimate-0.23-0.63-1.89-2.15
High Estimate1.49-0.220.73-0.55
Year Ago EPS-0.26-0.16-1.14-0.28
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. Estimate64.25M12.72M125.7M96.32M
Low Estimate8M8M35M63M
High Estimate221M19.4M253M134.5M
Year Ago SalesN/A17.07M63.21M125.7M
Sales Growth (year/est)N/A-25.50%98.90%-23.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.33-0.29-0.22-0.08
EPS Actual-0.26-0.16-0.21-0.22
Difference0.070.130.01-0.14
Surprise %21.20%44.80%4.50%-175.00%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate0.73-0.42-0.28-1.27
7 Days Ago0.73-0.42-0.28-1.27
30 Days Ago0.47-0.34-0.33-1.01
60 Days Ago-0.21-0.13-0.75-0.69
90 Days Ago0.03-0.01-0.26-0.56
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3N/A3N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLXRXIndustrySectorS&P 500
Current Qtr.380.80%N/AN/A-0.02
Next Qtr.-162.50%N/AN/A0.07
Current Year75.40%N/AN/A-0.02
Next Year-353.60%N/AN/A0.14
Next 5 Years (per annum)54.70%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A